PR Newswire All News ReleasesQwen · 实盘不做把握 2/10不做原因:标的无直接敞口
北京时间·🕒 发布 19:03:00·⟳ 抓取 19:03:33 +33s·⚡ 决策 09-01 19:16:31 +12m58s·56.2 天前
Veeva Systems 发布 Falcon Safety 药物安全 AI 产品，计划 2026 年 11 月开放早期用户
Veeva Systems 市值约 $40B+，本次为既有 Veeva Safety 产品的 AI 化扩展公告，未披露任何收入、客户承诺、订单金额或财务指引变化，产品 2026 年 11 月才开放早期用户。按超大市值软催化规则，无金额增量的自家产品发布不构成可交易催化。无二阶供应链或跨市场映射标的。
📄 原文PR Newswire All News Releases↗ 原文
Veeva Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels
PLEASANTON, Calif., Sept. 1, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Safety, an ag…
不做 Veeva Systems（VEEV.US）
超大市值（~$40B+）常规产品扩展公告，无收入/订单/客户承诺/财务指引变化，产品 11 月才开放早期用户，相对市值无可交易增量，属典型软催化
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Veeva 宣布 Falcon Safety 是 Veeva Safety 的 agentic AI 扩展，兼容所有 E2B 合规系统。公告未披露收入、客户承诺或财务影响，产品 11 月才开放早期用户。对 $40B+ 市值公司而言，这是常规产品路线图更新，不构成短线交易催化。竞品方 Oracle 市值 $400B+ 不受影响，ArisGlobal 为私有公司。无可交易标的和正期望。
🔎 新鲜度:最早出现 2026-09-01 · 扩散 low · price-in 风险 low ↗
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- fetch_decision_experience 成功 stock_tools HTTP · 304 ms
{
原文全文
展开原文 · 2,452 字
Veeva Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels
PLEASANTON, Calif., Sept. 1, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up to reduce costs, increase speed, and maintain compliance for biopharma companies of all sizes.
In addition to working seamlessly with Veeva Safety, Falcon Safety will provide intake and follow-up management for any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.
"We've had the privilege of working closely with case processors, pharmacovigilance experts, and safety specialists globally to build Veeva Safety," said Marius Mortensen, vice president of product, Falcon at Veeva. "With Falcon Safety, we're excited to build on that partnership to help the industry reinvent safety operations."
Planned for early adopter availability in November 2026, Falcon Safety is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended July 31, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.
Contact: |
|
Elizabeth McGrane |
Jeremy Whittaker |
SOURCE Veeva Systems
PLEASANTON, Calif., Sept. 1, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up to reduce costs, increase speed, and maintain compliance for biopharma companies of all sizes.
In addition to working seamlessly with Veeva Safety, Falcon Safety will provide intake and follow-up management for any E2B-compliant safety system, including Oracle Argus and ArisGlobal LifeSphere MultiVigilance.
"We've had the privilege of working closely with case processors, pharmacovigilance experts, and safety specialists globally to build Veeva Safety," said Marius Mortensen, vice president of product, Falcon at Veeva. "With Falcon Safety, we're excited to build on that partnership to help the industry reinvent safety operations."
Planned for early adopter availability in November 2026, Falcon Safety is part of Veeva AI, Veeva's industry-specific AI solutions for life sciences.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended July 31, 2026, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.
Contact: |
|
Elizabeth McGrane |
Jeremy Whittaker |
SOURCE Veeva Systems
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。